These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2428784)

  • 21. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thymus in "bare lymphocyte" syndrome: significance of expression of major histocompatibility complex antigens on thymic epithelial cells in intrathymic T-cell maturation.
    Schuurman HJ; van de Wijngaert FP; Huber J; Schuurman RK; Zegers BJ; Roord JJ; Kater L
    Hum Immunol; 1985 Jun; 13(2):69-82. PubMed ID: 3874194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of class II antigens in different routes of alloactivation.
    Sutherland R; Heath W; Boyle W
    Transplant Proc; 1986 Apr; 18(2):298-301. PubMed ID: 2938317
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells.
    Viguier M; Lotteau V; Charron D; Debré P
    Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of class II antigens by subsets of activated T cells.
    Zier KS
    Cell Immunol; 1986 Jul; 100(2):525-31. PubMed ID: 3093090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.
    Lightstone L; Hargreaves R; Bobek G; Peterson M; Aichinger G; Lombardi G; Lechler R
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5772-7. PubMed ID: 9159149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
    Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
    Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of MHC class II antigens in chronic B-cell disorders.
    Drexler HG; Gignac SM; Brenner MK; Coustan-Smith E; Janossy G; Hoffbrand AV
    Clin Exp Immunol; 1988 Feb; 71(2):217-23. PubMed ID: 2450706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA and bone marrow transplantation.
    Bach FH
    Prog Clin Biol Res; 1984; 149():257-70. PubMed ID: 6204340
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics of the human major histocompatibility complex.
    Auffray C; Strominger JL
    Adv Hum Genet; 1986; 15():197-247. PubMed ID: 3513484
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
    Fischer A; Sterkers G; Charron D; Durandy A
    Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigenic characteristics of hematopoietic stem cells].
    Tananov AT; Timakova LA
    Gematol Transfuziol; 1986 Feb; 31(2):48-53. PubMed ID: 2420680
    [No Abstract]   [Full Text] [Related]  

  • 39. T-cell proliferation and expression of MHC class II antigens.
    Brown G; Walker L; Ling NR; Richardson P; Johnson GD; Guy K; Steel CM
    Scand J Immunol; 1984 Apr; 19(4):373-7. PubMed ID: 6610209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCA: a polymorphic genetic marker in leukemias and melanoma cell lines.
    van Leeuwen A; Schrier PI; Giphart MJ; Noordermeer IA; Ruiter DJ; Rubinstein P; van Rood JJ
    Blood; 1986 Apr; 67(4):1139-42. PubMed ID: 3485457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.